Prime Medicine Share Price Today
(NASDAQ: PRME)

Name: Prime Medicine Share Price Today (NASDAQ: PRME) - Prime Medicine Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Prime Medicine share price is $1.24 & ₹105.98 as on 18 Apr 2025, 2.30 'hrs' IST

$1.24

Market is closed - opens 7 PM, 21 Apr 2025

View live Prime Medicine share price in Dollar and Rupees. Guide to invest in Prime Medicine stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Prime Medicine, along with analyst recommendations, forecasts, and comprehensive financials.

Prime Medicine share price movements

Today's Low: $1.22
Today's High: $1.28
$1.24
2.02%
Downside
Day's Volatility :5.08%
Upside
3.13%
52 Weeks Low: $1.12
52 Weeks High: $8.27
$1.24
10.08%
Downside
52 Weeks Volatility :86.52%
Upside
85.01%

Prime Medicine (PRME) Returns

Period	Prime Medicine, Inc.	Index (Russel 2000)
3 Months	-57.39%	0.0%
6 Months	-71.62%	0.0%
1 Year	-72.51%	0.0%
3 Years	-91.93%	-12.9%

Prime Medicine (PRME) Key Statistics

in dollars & INR

Previous Close	$1.24
Open	$1.24
Today's High	$1.28
Today's Low	$1.215
Market Capitalization	$162.6M
Today's Volume	$457.8K
52 Week High	$8.27
52 Week Low	$1.115
Revenue TTM	$3.0M
EBITDA	$-196.3M
Earnings Per Share (EPS)	$-1.65
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-136.88%

How to invest in Prime Medicine Stock (PRME) from India?

It is very easy for Indian residents to invest directly in Prime Medicine from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Prime Medicine stock in both Indian Rupees (INR) and US Dollars (USD). Search for Prime Medicine or PRME on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Prime Medicine or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Prime Medicine shares which would translate to 0.689 fractional shares of Prime Medicine as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Prime Medicine, in just a few clicks!

Returns in Prime Medicine (PRME) for Indian investors in Rupees

The Prime Medicine stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Prime Medicine investment value today

Current value as on today

₹29,835

Returns

₹70,165

(-70.16%)

Returns from Prime Medicine Stock

₹72,506 (-72.51%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Prime Medicine (PRME)

-4%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Prime Medicine Stock from India on INDmoney has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Prime Medicine

Alphabet Inc
11.48%
ARK Investment Management LLC
3.93%
BlackRock Inc
3.45%
T. Rowe Price Investment Management,Inc.
3.03%
FMR Inc
2.90%
Vanguard Group Inc
2.79%

Analyst Recommendation on Prime Medicine

Rating

Trend

Buy

76%Buy

23%Hold

0%Sell

Based on 17 Wall street analysts offering stock ratings for Prime Medicine(by analysts ranked 0 to 5 stars)

Analyst Forecast on Prime Medicine Stock (PRME)

What analysts predicted

Upside of 956.45%

Target:

$13.10

Current:

$1.24

Insights on Prime Medicine Stock (Ticker Symbol: PRME)

Price Movement
In the last 7 days, PRME stock has moved down by -6.8%
PRME vs ONC (1 yr)
In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 148.6%
Price to Sales
ForPRME every $1 of sales, investors are willing to pay $49.6, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

Prime Medicine Technicals Summary

Sell

Neutral

Buy

Prime Medicine is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Prime Medicine (PRME) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Prime Medicine, Inc.	-38.31%	-71.62%	-72.51%	-91.93%	-91.93%
Regeneron Pharmaceuticals, Inc.	-17.1%	-41.85%	-37.2%	-21.74%	-0.85%
Beone Medicines Ltd	-13.12%	5.03%	78.34%	40.23%	43.44%
Vertex Pharmaceuticals Incorporated	-4.76%	2.3%	24.05%	71.43%	78.99%
Alnylam Pharmaceuticals, Inc.	-9.09%	-19.67%	62.43%	39.66%	61.91%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Prime Medicine, Inc.	NA	NA	NA	-1.15	-1.37	-0.52	NA	1.2
Regeneron Pharmaceuticals, Inc.	14.68	14.68	0.9	41.18	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.09	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.34	17.96	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.81	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Prime Medicine, Inc.	Buy	$162.6M	-91.93%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$60.5B	-0.85%	14.68	31.07%
Beone Medicines Ltd	NA	$26.9B	43.44%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$125.7B	78.99%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$30.4B	61.91%	NA	-12.37%

About Prime Medicine

Prime Medicine, Inc., a biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States. It offers Prime Editing technology comprising a programmable DNA binding domains, such as Cas domains, are typically modified such that they do not cause a double-stranded break in the DNA, as well as a RT domain that copies the edited DNA sequence directly into the target genomic site where the edit is made; and pegRNA which contains a search sequence, also known as a spacer, which provides a target genomic address for the Prime Editor. The company has a research collaboration with Cimeio Therapeutics to develop Prime Edited Shielded-Cell & Immunotherapy Pairs for genetic diseases, acute myeloid leukemia, and myelodysplastic syndrome. Prime Medicine, Inc. was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.

Organization	Prime Medicine
Employees	214
CEO	Dr. Keith Michael Gottesdiener M.D., Ph.D.
Industry	Miscellaneous

Management People of Prime Medicine

Name	Title
Dr. Keith Michael Gottesdiener M.D., Ph.D.	President, CEO, Secretary & Director
Dr. Ann L. Lee Ph.D.	Chief Technical Officer
Dr. Jeremy S. Duffield M.D., Ph.D.	Chief Scientific Officer
Dr. Andrew Anzalone M.D., Ph.D.	Co-Founder & Head of Prime Editing Platform
Dr. David R. Liu Ph.D.	Co-Founder & Member of Scientific Advisory Board
Dr. Allan Reine M.D.	Chief Financial Officer
Dr. Meredith Goldwasser	Senior VP and Head of Strategy & Corporate Operations
Ms. Carman Alenson CPA, M.B.A.	Senior VP of Finance & Chief Accounting Officer
Dr. Karen Brown J.D., Ph.D.	Senior Vice President of Intellectual Property & Legal Affairs
Ms. Niamh Alix	Chief Human Resources Officer

Important FAQs about investing in PRME Stock from India :

What is Prime Medicine share price today?

Prime Medicine share price today stands at $1.24, Open: $1.24 ; Previous Close: $1.24 ; High: $1.28 ; Low: $1.22 ; 52 Week High: $8.27 ; 52 Week Low: $1.12.

The stock opens at $1.24, after a previous close of $1.24. The stock reached a daily high of $1.28 and a low of $1.22, with a 52-week high of $8.27 and a 52-week low of $1.12.

Can Indians buy Prime Medicine shares?

Yes, Indians can invest in the Prime Medicine (PRME) from India.

With INDmoney, you can buy Prime Medicine at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Prime Medicine at zero transaction cost.

How can I buy Prime Medicine shares from India?

It is very easy to buy Prime Medicine from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Prime Medicine (PRME) be purchased?

Yes, you can buy fractional shares of Prime Medicine with INDmoney app.

What are the documents required to start investing in Prime Medicine stocks?

To start investing in Prime Medicine, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.